Photo

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Best of Cannes

Style and scenes from the Cannes Film Festival.  Slideshow 

Photo

Ethiopia's salt trails

For centuries merchants have traveled to Ethiopia to collect salt from the surface of the vast desert basin.  Slideshow 

Sponsored Links

Glaxo reaches $150 million settlement in nasal spray litigation

Related Topics

A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville

A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008.

Credit: Reuters/Toby Melville

Wed Dec 19, 2012 12:15pm EST

(Reuters) - British drugmaker GlaxoSmithKline Plc has reached a $150 million preliminary settlement with U.S. drug wholesalers who claimed the company improperly delayed entry to the market of generic alternatives to its nasal spray Flonase, according to court documents.

The settlement was reached with, among others, AmerisourceBergen Corp, Cardinal Health Inc, and McKesson Corp, who maintained that Glaxo had abused the citizen's petition process to maintain a market monopoly and overcharge for the spray by restricting access to less expensive generic versions.

The preliminary settlement was approved by the United States District Court for the Eastern District of Pennsylvania.

(Reporting By Toni Clarke; Editing by Gerald E. McCormick)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.